Pteridine derivatives with nitric oxide synthase inhibitor function
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2004-11-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the design and synthesis of pteridine derivatives capable of controlling excessive production of nitric oxide free radicals (NO·, abbreviated as NO) in the body, especially pteridine derivatives with the effect of inducible NO synthase inhibitors. Medicines for preventing and treating diseases mediated by elevated NO levels in the body can be prepared.
[0002] This invention research work was funded by the National Natural Science Foundation of China (Project No. 39870822). Background of the invention
[0003] NO is a bioactive molecule with low molecular weight and hydrophobic properties, which can freely pass through the cell membrane and act on target molecules in the cell. Theoretically, NO can reach any part of the cell and tissue, so it can regulate various cell functions and Produce a wide range of biological effects. NO is produced by endogenous nitric oxide synthase (NO Synthase, abbreviated as NOS). NOS use...